Crystal Crop Protection IPO GMP falls to ₹27 ahead of issue
Key highlights
- Crystal Crop Protection IPO's reported GMP was ₹27 per share on 15 November 2026, about 10% above the ₹272 upper band.
- The reported ₹27 GMP implied a ₹299 price, calculated by adding it to the ₹272 upper price band.
- The reported GMP fell ₹3 from ₹30 on 14 November and was below the ₹40 quote on 13 November.
- The ₹455.5 crore IPO is scheduled to open on 18 November 2026 at a ₹259 to ₹272 price band.
powered by IRIS

On 15 November 2026, Crystal Crop Protection IPO's reported grey market premium fell ₹3 to ₹27 per share, implying an indicative ₹299 price against the ₹272 upper price band. The latest unofficial quote equals about a 10% premium, down from ₹40 on 13 November and ₹30 in the previous recorded quote.
What is the latest Crystal Crop Protection IPO GMP?
The IPO's latest reported GMP is ₹27 per share as of 8:00 AM IST on 15 November, according to the social-media and grey-market tracking context. At the ₹272 upper end of the price band, that premium works out to roughly 9.9% to 10%.
Adding the ₹27 reported premium to the upper band produces an indicative price of ₹299 per share. This is a mathematical illustration based on the reported grey-market quote, not a forecast of where the shares will list. The IPO has a price band of ₹259 to ₹272 per share and is scheduled to open on 18 November.
Why has the IPO GMP declined from earlier quotes?
The reported GMP has declined from ₹40 on 13 November to ₹27 on 15 November, a fall of ₹13 over the three recorded dates. Other reported data points put the 13 November quote at ₹45, underlining that grey-market readings can differ across trackers and times of day.
The available context does not identify a verified reason for the change. It says the premium reflects soft grey-market demand over the last three sessions, but it also notes that no official source publishes a reason for a GMP level. Any explanation beyond the reported movement would therefore be speculative.
Across the wider recorded period, the IPO's GMP ranged from ₹27 to ₹45. One tracker also showed ₹0 on 12 November, while another cited ₹12 on that date. These differences reinforce that grey-market figures are privately quoted indications rather than standardised market data.
Does the IPO GMP guarantee a ₹299 listing price?
No, the IPO's ₹299 indicative price does not guarantee its eventual listing price. GMP is an informal, unregulated grey-market indicator and is not published or recognised by the Securities and Exchange Board of India, the National Stock Exchange of India, or the BSE.
The actual listing outcome can differ from a GMP-based calculation. The context notes that recent IPO listings have produced uneven outcomes, including gains and losses relative to issue prices. Investors should separate the informal pre-listing quote from official issue terms, subscription data and the eventual exchange-traded opening price.
The ₹299 figure only adds the latest ₹27 quote to the ₹272 upper band. It should not be treated as investment advice, an allotment indicator or a measure of the company's valuation after listing.
Got a follow-up? Ask IRIS
What are the IPO terms and key dates?
The IPO is a ₹455.5 crore public issue with a ₹259 to ₹272 per-share price band and is due to open on 18 November. It is among the public issues expected in the week beginning 16 November, after a relatively subdued Diwali-period primary-market calendar.
Earlier reports on 13 November put the unofficial GMP at ₹45 to ₹48, or roughly 16% to 18% over the upper band. By 15 November, the reported ₹27 premium had brought that indication down to about 10%. The change shows how quickly informal pre-listing sentiment can shift before an issue opens.
The near-term reference point is the opening of the issue on 18 November. Until then, any GMP movement remains an unofficial quote, while the stated price band and issue size are the disclosed terms investors can use for comparison.
How should retail investors read the GMP trend?
Retail investors should view the IPO's lower GMP as a sentiment data point rather than a trading signal. A ₹27 premium suggests that grey-market participants were last quoting shares above the upper band, but the fall from higher readings shows that such sentiment is not fixed.
The broader IPO market context is mixed. The National Stock Exchange of India's reported GMP had fallen nearly 32% in September in a separate example, while different current issues showed widely different implied premiums. That variation means one issue's grey-market movement cannot establish a market-wide conclusion.
Conclusion
The IPO's reported GMP has moderated to ₹27, producing an indicative ₹299 price at the ₹272 upper band, compared with higher reported premiums of ₹40 or ₹45 on 13 November. The movement points to softer unofficial sentiment, but it does not provide a reliable prediction of the listing price.
The next disclosed event is the issue opening on 18 November at the ₹259 to ₹272 price band. Investors can watch whether the reported GMP remains near ₹27 as the opening approaches, while keeping in mind that subscription developments and the eventual exchange listing will provide more concrete market signals.


